SCHEMBL30168731

SCHEMBL30168731

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 1/20 0.64
▸ MAPK9 P45984 1/20 0.64
▸ MAPK10 P53779 1/20 0.64
▸ NPY2R P49146 8/20 0.59
▸ NPY4R P50391 8/20 0.59
▸ NPY5R Q15761 8/20 0.59
▸ NPY1R P25929 6/20 0.59
▸ EP300 Q09472 1/20 0.55
▸ HIF1A Q16665 1/20 0.55
▸ TFPI P10646 4/20 0.55
▸ KEAP1 Q14145 1/20 0.53
▸ NMUR2 Q9GZQ4 1/20 0.53
▸ NMUR1 Q9HB89 1/20 0.53
▸ VIPR2 P41587 1/20 0.52
▸ KDM1A O60341 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29554773 0.92 MAPK8 (0.64) MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL30262189 0.91 NPY2R (0.60) MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL29679864 0.89 MAPK8 (0.62) MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL30428447 0.88 MAPK8 (0.70) MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL30432762 0.88 MAPK8 (0.65) MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL30607334 0.87 NPY2R (0.68) NPY2RNPY4RNPY5RNPY1REP300
SCHEMBL30432199 0.87 NPY2R (0.67) MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL29608162 0.86 MAPK8 (0.63) MAPK8MAPK9MAPK10
SCHEMBL38666025 0.86 EP300 (0.62) MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL5499227 0.86 MAPK8 (0.58) MAPK8MAPK9MAPK10EP300HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12428638-B2 Three-component CRISPR/Cas complex system and uses thereof THE JACKSON LABORATORY (US) 2025-09-30 — — US disclosed
US-20230071712-A1 THREE-COMPONENT CRISPR/CAS COMPLEX SYSTEM AND USES THEREOF THE JACKSON LABORATORY (US) 2023-03-09 — — US disclosed
Send feedback